The prevalence and association of vitamin D deficiency in urban psychiatric population

Program: Abstracts - Orals, Featured Poster Presentations, and Posters
Session: SUN 257-280-Disorders of Vitamin D Metabolism & Action
Basic/Translational
Sunday, June 16, 2013: 1:45 PM-3:45 PM
Expo Halls ABC (Moscone Center)

Poster Board SUN-259
Yin Htwe Oo*1, Naureen Kabani2, Amir Kalani3, Alan Scott Sacerdote4, Samy I McFarlane5 and Gul Bahtiyar6
1SUNY Downstate, Brooklyn, NY, 2St. George’s University School of Medicine, Grenada, WI, 3St. George’s University School of Medicine, Brooklyn, NY, 4NYU School of Medicine, New York, NY, 5SUNY Health Sci Ctr-Brooklyn, Brooklyn, NY, 6Woodhull Medical Center, Brooklyn, NY
Background

Several studies confirm higher prevalence of vitamin D insufficiency or deficiency in psychiatric patients. The incidence is highest in schizophrenic patients. However, up to this date, it is not conclusive that vitamin D deficiency is a cause or effect of psychiatric illnesses. In addition to a few commonly known contributing factors for vitamin D deficiency in general population such as inadequate sun exposure and poor nutritional intake, some of anti-psychotic medications are known to interfere with intrinsic vitamin D synthesis.

Objective

The objective of this study is to identify the prevalence and metabolic association of vitamin D deficiency in urban psychiatric population.

Method

This is a cross-sectional analysis of 108 psychiatric patients in an urban municipal hospital in Brooklyn, New York. Vitamin D levels were obtained to assess the prevalence of vitamin D deficiency and insufficiency and to examine the association of such deficiency on other metabolic parameters.

Result

Mean age (±SD) was 41.0 (±14.2) and mean BMI (±SD) was 28.2 (± 7.4). Among the entire study population, 70% had vitamin D deficiency (25 OH vitamin D < 20 ng/ml) and 99% had vitamin D insufficiency (25 OH vitamin D < 30 ng/ml). There was no significant difference in age, gender, BMI, blood pressure, HbA1c, fasting blood glucose, creatinine, calcium, and TSH in patients with vitamin D deficiency when compared to patients with normal vitamin D values.

Conclusion

Vitamin D deficiency is highly prevalent in urban psychiatry population. Implications of such deficiency on clinical metabolic parameters are largely unclear.

1)Parker G, Brotchie H.'D' for depression: any role for vitamin D? 'Food for Thought' II. Acta Psychiatr Scand. 2011 Oct;124(4):243-9. 2)Jamilian H, Bagherzadeh K, Nazeri Z, Hassanijirdehi M. Vitamin D, parathyroid hormone, serum calcium and phosphorus in patients with schizophrenia and major depression. Int J Psychiatry Clin Pract. 2012 Apr 26. 3)Itzhaky D, Amital D, Gorden K, Bogomolni A, Arnson Y, Amital H. Low serum vitamin D concentrations in patients with schizophrenia. Isr Med Assoc J. 2012 Feb;14(2):88-92.   4)McCue RE, Charles RA, Orendain GC, Joseph MD, Abanishe JO. Vitamin d deficiency among psychiatric inpatients. Prim Care Companion CNS Disord. 2012;14(2). 5)Murie J, Messow CM, Fitzpatrick B. Feasibility of screening for and treating vitamin D deficiency in forensic psychiatric inpatients. J Forensic Leg Med. 2012 Nov;19(8):457-64. Xuan Y, Zhao HY, Liu JM. Vitamin D and Type 2 Diabetes. J Diabetes. 2013 Jan 10.

Nothing to Disclose: YHO, NK, AK, ASS, SIM, GB

*Please take note of The Endocrine Society's News Embargo Policy at http://www.endo-society.org/endo2013/media.cfm